2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds 2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 2: Orally bioavailable compounds Discovery and optimization of novel purines as potent and selective CB2 agonists Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists Novel benzimidazole derivatives as selective CB2 agonists Benzo[d]thiazol-2(3H)-ones as new potent selective CB2 agonists with anti-inflammatory properties 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB₂Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands Discovery and Optimization of a Novel Series ofN-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB₂) Agonists Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists